0000899243-15-009275.txt : 20151203 0000899243-15-009275.hdr.sgml : 20151203 20151203191436 ACCESSION NUMBER: 0000899243-15-009275 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151203 DATE AS OF CHANGE: 20151203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Applied Physics & Chemistry Laboratories, Inc. CENTRAL INDEX KEY: 0001611158 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 151268540 BUSINESS ADDRESS: STREET 1: 13760 MAGNOLIA AVENUE CITY: CHINO STATE: CA ZIP: 91710 BUSINESS PHONE: 909-590-1828 MAIL ADDRESS: STREET 1: 13760 MAGNOLIA AVENUE CITY: CHINO STATE: CA ZIP: 91710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-01 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001611158 Applied Physics & Chemistry Laboratories, Inc. 13760 MAGNOLIA AVENUE CHINO CA 91710 0 0 1 0 Common Stock 2015-12-01 4 S 0 20000 15.489 D 7611594 D Common Stock 2015-12-03 4 S 0 18583 15.4152 D 7593011 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.23 to $15.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.05 to $15.80, inclusive. Jack Y. Zhang (''Dr. Zhang'') is the Chief Executive Officer and a director of the Issuer and Mary Z. Luo (''Dr. Luo'') is the Chief Operating Officer and Chairman of the Board of Directors of the Issuer. Drs. Zhang and Luo are the sole owners of the Reporting Person and have shared voting and investment power of the Reporting Person. /s/ Ken Stupak, Corporate Counsel 2015-12-03